J774 macrophage-like cell line cytokine and chemokine patterns are modulated by Francisella tularensis LVS strain infection
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- buněčné linie MeSH
- chemokiny imunologie MeSH
- cytokiny imunologie MeSH
- Francisella tularensis imunologie MeSH
- makrofágy imunologie mikrobiologie MeSH
- myši MeSH
- tularemie imunologie mikrobiologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- chemokiny MeSH
- cytokiny MeSH
Mutual interactions were investigated between intracellular parasitic bacterium Francisella tularensis (F.t.; highly virulent bacterium responsible for tularemia, replicating within the host macrophages) and murine macrophage-like cell line J774. Recombinant murine lymphokine INF-gamma and/or LPS derived from E. coli were determined to stimulate in vitro antimicrobial activity of macrophage-like J774 cell line against the live vaccine strain (LVS) of F.t. through their ability to produce proinflammatory cytokines and chemokines. F.t. infection up-regulated IL-12 p40 production and down-regulated TNF-alpha production by stimulated macrophages; on the other hand, F.t. infection did not affect the production of IL-8, IL-6, MCP-5, and RANTES by stimulated macrophages. This showed that F.t. infection modulates the cytokine synthesis by J774 macrophage cell line.
Zobrazit více v PubMed
Cytokine. 2005 Dec 21;32(6):304-15 PubMed
Microbes Infect. 2005 Apr;7(4):619-25 PubMed
Folia Microbiol (Praha). 2000;45(5):457-63 PubMed
J Immunol. 1992 Mar 15;148(6):1829-34 PubMed
Cytokine Growth Factor Rev. 1999 Mar;10(1):61-86 PubMed
Microbes Infect. 2006 Feb;8(2):561-7 PubMed
J Leukoc Biol. 2004 Feb;75(2):163-89 PubMed
Methods. 1999 Sep;19(1):121-32 PubMed
J Leukoc Biol. 2000 Dec;68(6):897-902 PubMed
Trends Immunol. 2001 Feb;22(2):83-7 PubMed
Microb Pathog. 2006 Dec;41(6):218-25 PubMed
Folia Microbiol (Praha). 2007;52(4):325-30 PubMed
Int Immunol. 2006 May;18(5):785-95 PubMed
Agents Actions. 1989 Jan;26(1-2):158-9 PubMed
Infect Immun. 1995 Feb;63(2):534-8 PubMed
Infect Immun. 1995 Apr;63(4):1478-83 PubMed
Immunity. 2000 Feb;12(2):121-7 PubMed
Folia Microbiol (Praha). 2004;49(6):737-44 PubMed
Infect Immun. 2003 Oct;71(10):5940-50 PubMed
Folia Microbiol (Praha). 2007;52(2):194-8 PubMed
Folia Microbiol (Praha). 2007;52(6):631-6 PubMed
Infect Immun. 1992 Mar;60(3):817-25 PubMed
Folia Microbiol (Praha). 2009;54(4):263-72 PubMed
Protein Expr Purif. 2006 Jan;45(1):132-41 PubMed
Hum Immunol. 2007 Aug;68(8):675-80 PubMed
Infect Immun. 2001 Jul;69(7):4691-4 PubMed
Cell Microbiol. 2003 Jan;5(1):41-51 PubMed
J Immunol. 1994 Aug 1;153(3):1238-45 PubMed
Folia Microbiol (Praha). 2001;46(3):259-64 PubMed
Diagn Microbiol Infect Dis. 1990 Sep-Oct;13(5):411-21 PubMed
FEMS Immunol Med Microbiol. 1996 Mar;13(3):239-44 PubMed
Microb Pathog. 2005 May-Jun;38(5-6):239-47 PubMed
Adv Drug Deliv Rev. 2005 Jun 17;57(9):1403-14 PubMed
Cytokine. 2003 Jan 21;21(2):65-73 PubMed
Cytokine Growth Factor Rev. 2002 Apr;13(2):155-68 PubMed
Infect Immun. 1999 Apr;67(4):1789-97 PubMed
FEMS Microbiol Lett. 2003 May 28;222(2):273-80 PubMed
